Adaptin Bio (APTN) Share-based Compensation (2025 - 2026)
Adaptin Bio's (APTN) quarterly Share-based Compensation came in at $2.3 million in Q2 2026, up 55.27% quarter-over-quarter from $1.5 million in Q1 2026.
Powered by 
Analysis
Adaptin Bio (APTN) Share-based Compensation (2025 - 2026) Analysis & Trends
Adaptin Bio has disclosed Share-based Compensation across 2 years of filings, most recently posting $2.3 million for Q2 2026.
- In Q2 2026, Share-based Compensation changed N/A year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, changed N/A from the prior year.
- Share-based Compensation came in at $2.3 million for Q2 2026 at Adaptin Bio, up from $1.5 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2026 to a low of -$75000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 14.16 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 17.32 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 17.57 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 17.40 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 40.78 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 90.90 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 3.58 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 28.03 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 9.08 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | 2.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | -75,000.00 |
| Sep 30, 2025 | 1.43 Mn |